Centaurus Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,041
Closed -$143K 855
2024
Q2
$143K Sell
1,041
-8
-0.8% -$1.1K 0.01% 691
2024
Q1
$144K Buy
1,049
+10
+1% +$1.37K 0.01% 688
2023
Q4
$141K Sell
1,039
-224
-18% -$30.4K 0.01% 676
2023
Q3
$154K Sell
1,263
-30
-2% -$3.66K 0.01% 634
2023
Q2
$164K Sell
1,293
-931
-42% -$118K 0.01% 616
2023
Q1
$287K Sell
2,224
-750
-25% -$96.8K 0.02% 553
2022
Q4
$390K Buy
2,974
+1,181
+66% +$155K 0.04% 423
2022
Q3
$210K Sell
1,793
-129
-7% -$15.1K 0.02% 606
2022
Q2
$226K Buy
1,922
+237
+14% +$27.9K 0.02% 573
2022
Q1
$220K Sell
1,685
-134
-7% -$17.5K 0.02% 638
2021
Q4
$278K Sell
1,819
-655
-26% -$100K 0.02% 591
2021
Q3
$400K Sell
2,474
-635
-20% -$103K 0.03% 475
2021
Q2
$509K Buy
3,109
+1,667
+116% +$273K 0.04% 428
2021
Q1
$217K Buy
1,442
+26
+2% +$3.91K 0.02% 577
2020
Q4
$215K Sell
1,416
-135
-9% -$20.5K 0.02% 537
2020
Q3
$210K Sell
1,551
-99
-6% -$13.4K 0.03% 442
2020
Q2
$226K Buy
1,650
+7
+0.4% +$959 0.03% 397
2020
Q1
$177K Sell
1,643
-1,961
-54% -$211K 0.04% 365
2019
Q4
$434K Buy
3,604
+1,237
+52% +$149K 0.06% 332
2019
Q3
$236K Buy
2,367
+545
+30% +$54.3K 0.04% 383
2019
Q2
$199K Buy
1,822
+1,661
+1,032% +$181K 0.03% 423
2019
Q1
$1.44K Buy
161
+16
+11% +$144 0.01% 507
2018
Q4
$2 Buy
145
+142
+4,733% +$2 0.01% 407
2018
Q3
$358 Sell
3
-4,077
-100% -$487K 0.06% 284
2018
Q2
$448K Buy
4,080
+934
+30% +$103K 0.06% 327
2018
Q1
$336K Buy
3,146
+233
+8% +$24.9K 0.08% 249
2017
Q4
$311K Buy
+2,913
New +$311K 0.08% 238